# Shorter Cycle Maintains Efficacy of Colorectal Cancer Regimen

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/hematologyoncology/coloncancer/123883) · 2026-11-13 · Medicine
Page: https://themorning.science/story/shorter-cycle-maintains-efficacy-of-colorectal-cancer-regimen-54d011196e4e0532
Kind: research · Impact: medium

## In brief

- A phase III trial from Japan, PRABITAS, tested a shorter cycle length for a standard treatment for refractory metastatic colorectal cancer.
- The shorter cycle was noninferior to the typical longer cycle for overall survival (OS).
- The shorter cycle also limited toxicity.

## Why it matters

For patients with refractory metastatic colorectal cancer, a shorter cycle may keep survival comparable while causing less toxicity, which could inform how the regimen is scheduled.

## Coverage

- [Shorter Cycle Maintains Efficacy of Colorectal Cancer Regimen](https://www.medpagetoday.com/hematologyoncology/coloncancer/123883) — MedPageToday.com - medical news for physicians, 2026-11-13

Tags: colorectal cancer, oncology, clinical trial, chemotherapy scheduling, toxicity

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science